|Bid||146.01 x 900|
|Ask||148.99 x 1100|
|Day's Range||147.57 - 148.86|
|52 Week Range||110.31 - 150.17|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||14.84|
|Earnings Date||Jan 27, 2020|
|Forward Dividend & Yield||1.60 (1.08%)|
|Ex-Dividend Date||Nov 27, 2019|
|1y Target Est||163.17|
TriStar Health opened its new Pinewood Springs behavioral health hospital Tuesday, the latest piece of construction completed as part of $500 million worth of improvements to the health system's network.
A Frisco health-tech company is joining the biggest hospital operator in the country. Valify has been acquired by HCA Healthcare (NYSE: HCA), which has a market valuation of more than $40 billion, the Nashville-based company said in a statement. Last year, it made the list of the Dallas area’s fastest-growing private companies with a ranking of No. 86, according to research by the the Caruth Institute for Entrepreneurship at Southern Methodist University’s Cox School of Business.
(Bloomberg) -- A former hedge fund trader who did a stint at Citadel was fined by U.S. regulators for illicitly profiting from tips that the Affordable Care Act was a much bigger boon for HCA Healthcare Inc. than the company expected.While working at Stelliam Investment Management, Michael Mindlin obtained non-public information in 2014 from an unnamed executive at HCA who had been a close friend for years, the Securities and Exchange Commission said in a Friday order. Mindlin, who didn’t admit or deny the allegations, agreed to pay $134,086 in penalties and agreed to an industry bar with the right to reapply after three years.Mindlin was at Stelliam from 2009 to March 2016 and Citadel from June 2016 to June 2018, according to his LinkedIn page. Mindlin’s attorney didn’t respond to a request for comment.In a statement, Stelliam confirmed it employed Mindlin when the HCA trades took place, while adding that it wasn’t aware of his alleged misconduct at the time. Citadel said it didn’t learn of the SEC investigation until Friday, adding that the regulator’s claims have nothing to do with the firm.In its order, the SEC said the HCA executive had reviewed internal reports that indicated Obamacare was having a more positive impact on the company’s earnings than previously anticipated. After receiving that information in phone conversations, Mindlin bought 717,500 shares of HCA in June 2014 for his firm, according to the regulator. The SEC didn’t name Mindlin’s employer.Raising ForecastLess than a month later, HCA reported its quarterly results and raised its annual profit forecast. Shares jumped more than 10% on the news, and Mindlin’s employer made more than $3.3 million after selling its entire stake in the company.“Stelliam was not aware of the conduct described in the order at the time the SEC found it to have occurred,” the firm said in an emailed statement. “Subsequent to the time the former employee left the firm for another employment opportunity, the firm was notified of an investigation involving this former employee and cooperated fully with the investigation. Stelliam’s polices prohibited the type of conduct described in the order and those policies were well understood by everyone who worked at the firm.”“This matter has absolutely nothing to do with Citadel,” the hedge fund firm said in a statement. “The person was not employed at Citadel during the relevant time, the trades at issue had nothing to do with Citadel and until today nobody at Citadel was even aware of this inquiry.”(Adds comment from Citadel, starting in fifth paragraph)To contact the reporter on this story: Matt Robinson in New York at firstname.lastname@example.orgTo contact the editors responsible for this story: Jesse Westbrook at email@example.com, Gregory MottFor more articles like this, please visit us at bloomberg.com©2020 Bloomberg L.P.
Valify provides health systems a suite of tools aimed at reducing costs through in-depth analysis, benchmark comparisons and advisory services
HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, today announced it has acquired Valify, a technology company focused on helping clients reduce the overall cost of healthcare services.
The partnership with Galen will provide nursing career development opportunities especially as the state faces a nurse shortage.
HCA is one of the largest employers of nurses in the country, with more than 94,000 working across the company’s 185 hospitals.
A Louisville-based nursing school that has grown into one of the nation's largest since its founding 30 years ago has been sold to a Nashville health care conglomerate. HCA Healthcare completed its acquisition of Galen College of Nursing today, after the company announced its intent to buy the school in March 2019. The acquisition of Galen effectively creates a pipeline for HCA, which could allow new nurses to feed the company's hospital system amid a nationwide shortage.
HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that it has acquired the majority ownership of the parent company of Galen College of Nursing, one of the largest educators of nurses in the United States.
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...
The health care industry plays a multibillion-dollar role in Orlando's economy, with hospital system giants like Altamonte Springs-based AdventHealth and Orlando Health among the area's highest employers. Some of those changes include continued adjustments to how health care companies seek to build some facilities, as well as impending worker shortages. Changes to Orlando's population also may affect needs for the area, including what type of projects businesses will go after.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of […]